Global /India /Healthcare /Drug Manufacturers - General /BIOFILCHEM

Biofil Chemicals and Pharmaceuticals Ltd.

BIOFILCHEM

• NSE: BIOFILCHEM • Delayed

34.05INR 1.2%

0.3606 USD

As of 23 June 2026, Biofil Chemicals and Pharmaceuticals Ltd. has a market cap of $5.78M USD, ranking #43890 globally and #3748 in India. It ranks #3890 in the Healthcare sector, and #1252 in the Drug Manufacturers - General industry.

Global Rank

43890

Country Rank

3748

Sector Rank

3890

Industry Rank

1252

Key Stats

Market Cap

$5.78MUSD

546.8M INR

Enterprise Value

$5.76MUSD

543.41M INR

Revenue (TTM)

$3.41MUSD

322.66M INR

EBITDA (TTM)

$378.36KUSD

35.72M INR

Net Income (TTM)

$293.25KUSD

27.73M INR

EBITDA Margin

11%

Profit Margin

8.6%

PE Ratio

19.7

PS Ratio

1.7

PB Ratio

2.6

EV/EBITDA

15.2

Company Profile

Country (HQ)

India

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Ketan Shah open_in_new

Employees

Founded

1985

Website

biofilgroup.net open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
1.2%	-0.9%	21%	14%	-14%	0.3%	-25%	-27%	-59%

News

Markets

Exchange	Ticker	Price	Quotes
National Stock Exchange of India (NSE) MIC: XNSE PRIMARY	BIOFILCHEM Biofil Chemicals & Pharmaceuticals Ltd ISIN: INE829A01014 Shares Out.: Shares Outstanding: 16.274M¹ TV: TradingView: NSE: BIOFILCHEM SA: Stock Analysis: NSE: BIOFILCHEM YF: Yahoo Finance: BIOFILCHEM.NS GF: Google Finance: NSE: BIOFILCHEM BA: Barron's: BIOFILCHEM MS: Morningstar: XNSE: BIOFILCHEM	34.05 INR	TV: TradingView: NSE: BIOFILCHEM SA: Stock Analysis: NSE: BIOFILCHEM YF: Yahoo Finance: BIOFILCHEM.NS GF: Google Finance: NSE: BIOFILCHEM BA: Barron's: BIOFILCHEM MS: Morningstar: XNSE: BIOFILCHEM
Bombay Stock Exchange (BSE / BOM) MIC: XBOM	524396 (BIOFILCHEM) Biofil Chemicals & Pharmaceuticals Ltd ISIN: INE829A01014 TV: TradingView: BSE: BIOFILCHEM SA: Stock Analysis: BOM: 524396 YF: Yahoo Finance: 524396.BO GF: Google Finance: BOM: 524396 BA: Barron's: 524396 MS: Morningstar: XBOM: 524396	33.60 INR	TV: TradingView: BSE: BIOFILCHEM SA: Stock Analysis: BOM: 524396 YF: Yahoo Finance: 524396.BO GF: Google Finance: BOM: 524396 BA: Barron's: 524396 MS: Morningstar: XBOM: 524396

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Biofil Chemicals and Pharmaceuticals Ltd.

Biofil Chemicals and Pharmaceuticals Limited engages in manufacturing and trading of pharmaceuticals in India. It operates through Pharmaceutical and Chemical divisions. The company offers basic drugs and chemicals, such as sodium chloride, potassium chloride, sodium citrate, diethyl carbamazine citrate, ferrous sulphate, dried ferrous sulphate, ferrous fumerate, micro crystalline cellulose, and dicyclomine hydrochloride; and packaging solutions. It also provides job work service for manufacturing pharmaceutical drugs. Biofil Chemicals and Pharmaceuticals Limited was incorporated in 1985 and is based in Indore, India.

Similar Companies

Industry: Drug Manufacturers - General (India)

Name	Market Cap (USD) diff.	PE	Country
Sun Pharmaceutical Industries Ltd. NSE: SUNPHARMA	$45.13B 4.27T INR 780K%	39.1	India
Divi's Laboratories Ltd. NSE: DIVISLAB	$18.34B 1.73T INR 317K%	70.0	India
Torrent Pharmaceuticals Ltd. NSE: TORNTPHARM	$15.14B 1.43T INR 262K%	63.0	India
Dr. Reddy's Laboratories Ltd. NSE: DRREDDY	$11.71B 1.11T INR 202K%	19.6	India
Mankind Pharma Ltd. NSE: MANKIND	$9.85B 931.67B INR 170K%	52.2	India
Zydus Lifesciences Ltd. NSE: ZYDUSLIFE	$9.69B 916.53B INR 168K%	18.6	India

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 13M%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 9M%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 6M%	97.4	United States
Roche Holding AG SIX: RO	$316.71B 256.25B CHF 5M%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$285.49B 215.59B GBP 5M%	27.6	United Kingdom
Merck & Co., Inc. NYSE: MRK	$274.03B 5M%	15.1	United States

chevron_leftBack